Back to search

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro

Data up to Jan 2025

Published1999
Citations522
References18

Total Citations Per Year

Abstract

References (18)

Oral Sildenafil in the Treatment of Erectile Dysfunction

1998 • 2,097 citations

Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms

1995 • 1,780 citations

EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN

1989 • 1,625 citations

Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

1996 • 1,070 citations

Oral Sildenafil in the Treatment of Erectile Dysfunction

1998 • 759 citations

The power of words.

1951 • 744 citations

Oral Sildenafil in the Treatment of Erectile Dysfunction

1998 • 627 citations

EFFECTS OF SILDENAFIL ON THE RELAXATION OF HUMAN CORPUS CAVERNOSUM TISSUE IN VITRO AND ON THE ACTIVITIES OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES

1998 • 595 citations

Clinical safety of oral sildenafil citrate (VIAGRATM) in the treatment of erectile dysfunction

1998 • 466 citations

Sildenafil citrate and blood-pressure–lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist

1999 • 339 citations

Nitric Oxide in the Regulation of Blood Flow and Arterial Pressure

1995 • 287 citations

Effects of sildenafil, a type‐5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro

1997 • 257 citations

Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells

1998 • 198 citations

Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.

1997 • 132 citations

Pharmacology of platelet-affecting drugs.

1980 • 103 citations

ROLE OF BRADYKININ IN THE NEONATAL RENAL EFFECTS OF ANGIOTENSIN CONVERTING ENZYME INHIBITION

1997 • 94 citations

Current Status of Phosphodiesterase Inhibitors in the Treatment of Congestive Heart Failure

1992 • 30 citations

ANTI-PLATELET ACTION OF NITRIC OXIDE AND SELECTIVE PHOSPHODIESTERASE INHIBITORS

1997 • 23 citations

Cited By (0)

Loading...